HS110 vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HS110 vaccine, covering 2013-11-21 to 2013-11-21. Get the full timeline:
Most recent: Clinical Trial Update: Immune Response and Safety of HS110 Vaccine in Combination With Erlotinib in Patients With Non-Small Cell Lung Cancer [Phase 2]